Sonnet BioTherapeutics

Sonnet biotherapeutics is working on developing new immune therapeutics.

Launch date

2011

Employees

Market cap

Net debt

-

Enterprise valuation

($717k) (Public information from Jun 2024)

Princeton New Jersey (HQ)

http://sonnetbio.com

https://twitter.com/sonnetbio https://www.linkedin.com/company/sonnet-biotherapeutics-inc./

Authorizing premium user...